The progressive inhibition of plasmin by pancreatic trypsin inhibitor and by a2-plasmin inhibitor in the presence of D-valyl-L-leucyl-L-lysine 4-nitroanilide was investigated. The kinetics with plasmin were compared with those with miniplasmin. The kinetic properties of two functionally different forms of a2-plasmin inhibitor described by Clemmensen [(1979) plasminogen-binding capability, and this difference can account for a difference in secondary site interaction suggested from the kinetics. The binding of inhibitor to miniplasmin is a simple pseudo-first-order reaction with both pancreatic trypsin inhibitor and the two a2-plasmin inhibitor forms. Such simple kinetics are also observed for the reaction between plasmin and the non-plasminogen-binding form of a2-plasmin inhibitor. More complicated kinetics are obtained for the reaction between plasmin and the a2-plasmin inhibitor form that binds to plasminogen. With both forms of the a2-plasmin inhibitor, a complex stable to acetic acid/urea and gel electrophoresis is present and fully developed 15 s after initiation of the reaction with plasmin.
reaction with plasmin.
Inactivation of the serine proteinase plasmin (EC 3.4.21 .7) by the specific inhibitor a2PI (a2-antiplasmin, primary plasmin inhibitor) is essential to the regulation of fibrinolysis. Inactivation kinetics of plasmin have been studied by Christensen & Clemmensen (1977 , Christensen (1979) , Wiman et al. ( , 1979 , Cederholm-Williams et al. (1979) and Wiman (1980a) . A reinvestigation of the kinetics by using carefully characterized a2PI preparations is of interest, since it has been indicated (Clemmensen, 1979; Wiman, 1980b ) that plasma may contain two functionally different forms of the inhibitor. One of these forms binds to plasminogen-Sepharose and the other does not. Much evidence suggests that the so-called lysine-binding sites on plasminogen that are involved in the interaction between the zymogen and a2PI are also involved as secondary sites in the interaction between plasmin and a2PI. The principal lysineAbbreviations used: SDS, sodium dodecyl sulphate; a2PI, a2-plasmin inhibitor; PBa2PI, plasminogen-binding a2PI; NPBa2PI, non-plasminogen-binding a2PI. Vol. 199 binding sites are located on the heavy chain of plasmin, whereas the catalytic site, which is the primary binding site for the inhibitor, is located on the light chain of plasmin (around serine-740). Secondary site interaction has a pronounced influence on the rate of inhibition [see Collen (1980) for a review].
In the present work, the kinetics of the two forms of the a2PI are compared with the kinetics obtained with a simple proteinase inhibitor of the Kunitz type, pancreatic trypsin inhibitor. Secondary site interactions are investigated by comparing the kinetics of Lys-plasmin (residues 77-790) and miniplasmin (residues 442-790), and also by studying the effect of the 'Iysine analogue', tranexamic acid (trans-4-aminomethylcyclohexane-1 -carboxylic acid).
A method in which the time course of proteinase inhibition can be followed continuously was introduced by Main & Dauterman (1963) . The (Thorsen & Muillertz, 1974) . Human urokinase was from Leo Pharmaceuticals, Copenhagen, Denmark. Gluplasminogen (residues 1-790) and '251-labelled plasminogen were prepared from outdated donor blood as previously described (Thorsen et al., 1981) . Plasmin was obtained by activating Gluplasminogen with Sepharose-bound urokinase as described by Wiman & Wallen (1973 Collen (1977) and Christensen & Clemmensen (1978) as described by Thorsen et al. (1981) . This purification procedure yields a preparation that contains approx. 90% a2PI which binds to plasminogen-Sepharose (PBa2PI). NBPa2PI is formed spontaneously from PBa2PI at room temperature (I. Clemmensen, unpublished work). The NPBa2PI preparation was obtained from a partially converted a2PI preparation from which NPBa2PI as removed by affinity chromatography on a plasminogen-Sepharose 4B column. NPBa2PI was collected in the void volume. On SDS/polyacrylamide-gel electrophoresis PBa2PI has Mr 67000, NPBa2PI has Mr 65000 and an inactive a2PI form (Ia2PI) has Mr 60000 (I. Clemmensen, unpublished work). The PBa2PI preparation used in the present study contained at least 90% of the Mr-67000 form. The NPBa2PI preparation contained no detectable PBa2PI (Mr 67000) but detectable amounts of Ia2PI (Mr 60000).
Determination ofprotein concentrations
The concentrations of Lys-plasmin and miniplasmin were determined from the kinetics of hydrolysis of D-valyl-L-leucyl-L-lysine 4-nitroanilide by using a millimolar absorption coefficient, 6410 8.48 x 103M-1 cm-for 4-nitroanilide and kcat= 13 s- (Christensen & Ipsen, 1979) . The concentration of plasminogen was determined after its conversion into plasmin (Thorsen & Miillertz, 1974) . The concentration of a2PI was determined by active-site titration with plasmin as described by Mullertz & Clemmensen (1976) .
Electrophoresis
SDS/polyacrylamide-gel electrophoresis was performed as described by Weber & Osborn (1975) , and acetic acid/urea/polyacrylamide-gel electrophoresis as described by Thorsen & Miillertz (1979 
Kinetic measurements
Buffer containing inhibitor and D-valyl-L-leucyl-L-lysine 4-nitroanilide was mixed with an equal volume of buffer containing plasmin by using a manual mixing device with two syringes connected to a flow cell. The dead-time of this simple stopped-flow system is approx. 5 s. The reaction was followed at 410nm with a Beckman Acta M VI spectrophotometer operating in the derivative mode, dA/dt. This enables a direct measurement of plasmin activity at any time after the reaction is started. Mixing plasma and substrate at the concentration used in this study-in the absence of inhibitor produces a constant activity for several minutes. All experiments were performed in 0.1 M-NaCI/0.05 MTris/HCI, pH 7.7 at 23 ± 2°C.
Theory
The reaction between a proteinase, E, and an irreversible competitive inhibitor, I, in the presence of substrate, A, may be described by the model (1) Because [El/[EA] is low at high substrate concentrations, the inhibition proceeds at a rate which is slow compared with that in the absence of substrate. Even with a high value of k1 it is therefore possible with substrate present to add relatively high concentrations of inhibitor and still be able to follow the reaction over a convenient time span. Assuming that steady state is rapidly established with respect to substrate, it is possible to derive eqn. (2) (Main & Dauterman, 1963; Aldridge & Reiner, 1972) for the relation between the plasmin activity, v, the Michaelis constant, KA, [Al and [II: 
Results Reaction between Lys-plasmin or miniplasmin and pancreatic trypsin inhibitor Fig. 1 shows the time course of the decrease in plasmin activity when plasmin is mixed with pancreatic trypsin inhibitor in the presence of 1.2 mM-D-valyl-L-leucyl-L-lysine 4-nitroanilide. The decrease is exponential, as indicated by the semilogarithmic plot of the results inserted in Fig. 1 . This plot is linear for more than 95% of the reaction. No residual plasmin activity could be observed at the end of the experiment, indicating that the inhibition is irreversible within the accuracy of the method, The effect of varying the concentration of inhibitor, I, is shown in Fig. 2 . centration of plasmin (results not shown). The inhibition kinetics of pancreatic trypsin inhibitor in the presence of substrate are thus fully consistent with eqn. (3), and it is possible to calculate the rate constant for the reaction between free plasmin and inhibitor, k1 = 5.6 x 1OM-1m5-1 (Table 1) . From  Fig. 3 it is also possible to determine the Michaelis constant for the steady-state kinetics with D-valyl-L-leucyl-L-lysine 4-nitroanilide, KA= 0.18 mM, which agrees well with the value of 0.15 mm obtained by conventional methods (Christensen & Ipsen, 1979) . The rate constant for the inhibition of miniplasmin by NPBa2PI is slightly lower than that for the inhibition by PBa2PI (Fig. 4 and Table 1 ). The effect of 1 mM-tranexamic acid on the reaction is also shown in Fig. 4 63.00) 6.5(2), 9.00 (1.82nM) and various concentrations of inhibitor as described in Fig. 1 longer strictly competitive with respect to substrate and that a model other than that described in eqn.
Inhibitor
(1) should be used in this case. Other methods appear to be better suited for measuring the kinetics under these conditions, and the rate constant for this initial reaction measured by those methods is given in Table 1 for comparison.
Addition of lysine analogues partially abolishes secondary site interactions (see, e.g., ; this is also indicated by the simple monophasic inactivation obtained with plasmin and PBa2PI in the presence of substrate and tranexamic acid (results not shown). The first-order rate constant for the inactivation reaction as a function of the concentration of PBa2PI is shown in Fig. 5 The plasmin inactivation by NPBa2PI is monophasic both in the absence and the presence of tranexamic acid (results not shown). Fig. 5 shows that, unlike the kinetics for PBa2PI, those for NPBa2PI are in accordance with the simple model described by eqn. (1). The rate constant for the reaction between plasmin and NPBa2PI in the Vol. 199 presence of tranexamic acid is identical, within experimental error, with the rate constant for the reaction between miniplasmin and NPBa2PI (Table  1) . Unlike the reaction with miniplasmin, the reaction with plasmin is slightly faster in the absence of tranexamic acid.
Appearance of complexes stable to acetic acid/urea and electrophoresis
The reaction between a2PI and plasmin results in a 1:1 complex that is stable to electrophoresis both on a SDS/polyacrylamide gel and on an acetic acid/urea/polyacrylamide gel (Miillertz & Clemmensen, 1976; Thorsen & Miillertz, 1979) . The rate of appearance of the stable complex was studied by mixing 1251-labelled plasmin with an excess of inhibitor. After 15, 30, 45, 120, 300 and 600 s, samples of the inhibitor-plasmin mixture were added to 1.75 M-acetic acid/9M-urea. Dilution into acetic acid/urea is supposed to cause an efficient quenching of the reaction, since a2P1 is known to be inactive both at low pH (Moroi & Aoki, 1976; Wiman & Collen, 1977) and at the high concentrations of urea (I. Clemmensen, unpublished work). The amount of stable complex formed was determined after separation of the complex by acetic acid/urea/ polyacrylamide-gel electrophoresis. The complex was quantified by counting the radioactivity of labelled material present in excised protein bands containing the complex, which were well separated from other bands with labelled material containing plasminogen (and possibly plasmin that had not reacted). A complex that is not dissociated under the conditions described above is fully developed 15s after mixing. This applies to complex-formation with PBa2PI as well as with NPBa2PI.
Discussion
The progressive inhibition of plasmin and miniplasmin was studied in the present work by a method in which proteinase and inhibitor are mixed in the presence of high concentrations of substrate. With a simple irreversible reaction between enzyme and inhibitor, the presence of substrate slows down the inactivation reaction by a factor a = (KA + [A])/KA.
Thus at a suitable high concentration of substrate, it is possible to use an ordinary spectrophotometer to follow the transient reaction between enzyme and inhibitor, even at relatively high concentrations of these components (Fig. 1) .
This 'substrate method' has not previously been applied to the study of the inhibition kinetics of proteinases from the haemostatic and fibrinolytic systems. The advantage of the method is that it is possible to follow the reaction at near-physiological concentrations of the proteinase, and that pseudofirst-order kinetics are obtained by addition of inhibitor in excess. This is in contrast with conventional methods, where the components have to be added in nanomolar concentrations (because of the high value of the second-order rate constant for the reaction between enzyme and inhibitor), and where more complicated kinetics are observed (see, e.g., Christensen & Clemmensen, 1978) . The 'substrate method' is therefore a valuable supplement to conventional methods.
A simple model (eqn. 1) gives a satisfactory description of the progressive inhibition of miniplasmin by pancreatic trypsin inhibitor as well as by NPBa2PI and PBa2PI. This is also true for the inhibition of plasmin by pancreatic trypsin inhibitor and NPBa2PI. The results suggest the existence of a strict competition between substrate and inhibitor, and also that the reaction between proteinase and inhibitor is a simple irreversible reaction. This is apparently in conflict with previous results (Christensen & Clemmensen, 1977 Christensen, 1979; Wiman, 1980a) , which suggests that the simplest possible model for the inactivation is that described by eqn. (4):
in which PI may be a complex with a 'virgin' inhibitor and PI* a complex with modified inhibitor (see, e.g., Laskowski & Kato, 1980) . However, it has been proposed (Christensen & Clemmensen, 1977 Wiman et al., , 1979 Wiman, 1980a) that both the dissociation reaction (k-1) and the conversion of PI into PI* (k+2) are relatively slow reactions. Half-times of 15-1500min for the first reaction (k-1) and 2-8min for the second reaction (k+2) have been estimated by the above authors.
This indicates that both reactions are insignificant within the time span of the experiments reported in the present work (typically 1-2min), and also that the method actually measures the second-order rate constant, k+l, for the reaction between free proteinase and inhibitor. The biphasic inhibition pattern observed by Christensen & Clemmensen (1977 and by (Christensen & Clemmensen, 1978; Christensen, 1979; or when residues 77-441 are removed from plasmin . The results listed in Table 1 confirm that a2PI is no more efTficient as an inhibitor than is pancreatic trypsin inhibitor under these conditions. It is also suggested from the results shown in Fig. 4 that a2PI and substrate compete for the same site on miniplasmin in a strict manner without secondary site interactions of the inhibitor. In agreement with the results obtained by , lysine analogues have an effect on the interaction of PBa2PI with the primary site of miniplasmin (Fig. 4) . This effect is not observed with NPBa2PI.
The fact that the reaction between plasmin and NPBa2PI is described by simple kinetics (eqn. 3) even in the absence of tranexamic acid (Fig. 5) suggests that secondary site interaction does not contribute to this reaction. It is plausible that PBa2PI contains a 'Iysine-like' site (complementary to the secondary site on the heavy chain of plasmin) that is modified or removed during the conversion of PBa2PI, contrary to what was observed with miniplasmin and NPBa2PI. Compared with the pronounced effect of tranexamic acid on the reaction between PBa2PI and plasmin, this is a minor effect that appears only to involve the primary site of plasmin. Since NPBa2PI may be present in significant amounts in plasma (Clemmensen, 1979; Wiman, 1980b) , this property of a2PI could be of physiological importance.
The plot of the apparent first-order rate constant for the reaction between plasmin and PBa2PI in the presence of tranexamic acid against the concentration of inhibitor (Fig. 5) does not pass through the origin. This could indicate that secondary site interaction is not completely abolished by addition of this lysine analogue, in contrast with what was observed when the secondary site interactions were abolished by replacement of plasmin with miniplasmin (Figs. 4 and 5) or by replacement of PBa2PI with NPBa2PI (Fig. 5) .
